Stellar Labs Raises $26.3 Million Series A Funding



Comments are closed.

Phase Four Raises $26m Series B led by New Science Ventures
QurAlis Closes $88 Million Series B to Advance Precision Medicines for Neurodegenerative Diseases
Alzeca Biosciences Closes $11 Million Series A Financing
Delix Therapeutics Awarded DoD Grant to Advance Neuroplastogen for Hearing Loss